NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting – Yahoo Finance

NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting – Yahoo Finance

NICE recommends first smartphone-based ECG for the detection of atrial fibrillation (AF) for people with suspected paroxysmal AF in an ambulatory monitoring setting – Yahoo Finance

DeFi expert Jim Bianco joins Jared Blikre to break down an interesting year ahead on Wednesday, 1/12 at 2PM ET.
– AliveCor's KardiaMobile® is the only personal electrocardiogram (ECG) to be recommended by the National Institute for Health and Care Excellence (NICE) for use within the NHS[1]
– NICE's positive recommendation[1] offers patients and physicians across England and Wales access to a medical-grade ECG to support at home monitoring of paroxysmal atrial fibrillation (AF) without the requirements for multiple hospital appointments
– AF, a type of irregular heart rhythm and leading cause of stroke, affects around 1.3 million people in the UK,[2] almost half of which remain undiagnosed[3]
– Paroxysmal AF occurs when AF symptoms, such as palpitations, are intermittent and self-terminating within seven days of onset
MOUNTAIN VIEW, Calif., Jan. 7, 2022 /PRNewswire/ — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the National Institute for Health and Care Excellence (NICE) has issued Medical Technologies Guidance (MTG) recommending KardiaMobile as an option for detecting atrial fibrillation (AF) for people with suspected paroxysmal AF, who present with symptoms such as palpitations and are referred for ambulatory ECG monitoring by a clinician. KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales. KardiaMobile would be prescribed by a healthcare professional for people experiencing arrhythmia (irregular heart rhythm) symptoms more than 24 hours apart. The instructions for use state that all interpretations of ECG recordings are reviewed by a healthcare professional and used to support clinical decision making.1
AF, the most common form of arrhythmia ,2 is a leading cause of AF-related stroke.4 Almost half of the 1.3 million people in the UK living with AF are undiagnosed,2,3 leaving them particularly at risk of suffering the life-changing, and often devastating, effects of this serious form of stroke.5 Stroke detection and prevention is key to the NHS Long Term Plan,6 in efforts to save thousands of lives and reduce the staggering costs of disease – approximately £3 billion per year direct costs to the NHS, with further £4 billion to the UK economy in lost productivity, disability and informal care.7
"AF diagnosis rates across the UK pre-pandemic were already too low. With difficulties in accessing in-person care and increased waiting times, concern is that diagnosis rates have fallen further, leaving thousands of people at risk of life-threatening cardiovascular complications, such as an AF-related stroke" said Professor Matt Reed, RCEM Professor, Consultant and NRS Fellow in Emergency Medicine, NHS Lothian. "With the NHS over-stretched, it is encouraging that NICE has recognised the value of utilising smart technology to support clinicians. Today's recommendation of KardiaMobile – a clinically-validated digital tool to allow people to monitor their heart rhythm at home, avoiding the need for hospital appointments – is a great step forward for cardiac services."
"Many people experience various symptoms but do not realise it may be a heart rhythm disorder such as AF. If medical attention is not sought it leaves them exposed to a much higher risk of AF-related stroke. KardiaMobile can be used to monitor a person's heart rhythm at any time, regardless of whether or not people show signs or symptoms of AF. This ultimately means AF can be detected faster, leading to a quicker diagnosis and therefore more lives being protected against AF-related stroke and consequences of suffering with AF," said Mrs Trudie Lobban MBE, Founder and Trustee of Arrhythmia Alliance & AF Association.
KardiaMobile is the world's most clinically-validated personal ECG. Unlike traditional ECGs, KardiaMobile provides a compact, patchless and wireless solution that can be used at any time and anywhere. The user starts a 30-second ECG recording on their smartphone via the Kardia app – by placing two fingers from each hand on each of the two top electrodes – enabling the patient to remotely capture a medical-grade recording of their heart activity. KardiaMobile provides instant detection of AF, bradycardia and tachycardia, which are leading indicators of cardiovascular disease. KardiaMobile can also detect normal heart rhythm, offering users peace of mind.
Commenting on the announcement, Priya Abani, CEO, AliveCor said, "AliveCor is proud to be able to offer the only NICE-recommended personal ECG to support remote cardiac care services for patients not in front of their cardiologist. Today's recommendation not only highlights the clinical superiority of KardiaMobile against the current standard of care, but also its position as a more cost-effective solution, therefore warranting its value as a clinical tool to support rapid diagnosis of AF."
NICE's recommendation of KardiaMobile as a clinically and cost-effective medical technology is supported by evidence from 27 different studies,1 including five randomised controlled trials.8,9,10,11,12 Data submitted to NICE, showed KardiaMobile was five times more efficacious at detecting heart rhythm problems than standard tests alone9, with greater usability.9,13
NICE's MTG evaluates new, innovative medical devices and diagnostics. It assesses medical technologies that deliver treatment, give greater independence to patients and detect or monitor medical conditions.
The NICE MTG recommendation can be found here: https://www.nice.org.uk/guidance/mtg64
About AliveCor
AliveCor, Inc. is transforming cardiological care using deep learning. The FDA-cleared KardiaMobile device is the most clinically-validated personal ECG solution in the world. KardiaMobile 6L provides instant detection of Atrial Fibrillation, Bradycardia, Tachycardia, Sinus Rhythm with Supraventricular Ectopy, Sinus Rhythm with Premature Ventricular Contractions, Sinus Rhythm with Wide QRS and Normal Sinus Rhythm in an ECG. Kardia is the first AI-enabled platform to aid patients and clinicians in the early detection of atrial fibrillation, the most common arrhythmia and one associated with a highly-elevated risk of stroke. AliveCor's enterprise platform allows third party providers to manage their patients' and customers' heart conditions simply using state-of-the-art tools that provide easy front-end and back-end integration to AliveCor technologies. AliveCor protects its customers with stringent data security and compliance practices, achieving HIPAA compliance and SOC2 Type 1 and Type 2 attestations. AliveCor is a privately-held company headquartered in Mountain View, Calif. "Consumer" or "Personal" ECGs are ECG devices available for direct sale to consumers. For more information, visit alivecor.com.
References

[1] NICE Medical Technologies Guidance. KardiaMobile for detecting atrial fibrillation (MTG64). Available at: https://www.nice.org.uk/guidance/mtg64. Last accessed January 2022.
[2] British Heart Foundation. Managing atrial fibrillation in primary care. Available at: https://www.bhf.org.uk/for-professionals/healthcare-professionals/innovation-in-care/managing-atrial-fibrillation-in-primary-care. Last accessed January 2022
[3] Heart Rhythm Alliance. Heart Rhythm Week. Available at: https://www.heartrhythmalliance.org/afa/uk/heart-rhythm-week. Last accessed January 2022.
[4] Heart Rhythm Alliance. AF-related stroke? AF-related stroke. Available at: https://www.heartrhythmalliance.org/afa/uk/af-related-stroke. Last accessed January 2022.
[5] Heart Rhythm Alliance. Atrial Fibrillation Management. Available at: https://www.heartrhythmalliance.org/files/files/Atrial%20Fibrillation%20Management_2010%20Full%20Report.pdf. Last accessed January 2022.
[6] NHS. Long Term Plan. Available at: https://www.longtermplan.nhs.uk/areas-of-work/stroke. Last accessed January 2022.
[7] NHS England. Press release: NHS stroke action will save hundreds of lives. Available at: https://www.england.nhs.uk/2019/05/nhs-stroke-action-will-save-hundreds-of-lives/. Last accessed January 2022.
[8] Goldenthal IL, Sciacca RR, Riga T, et al. Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results. J Cardiovasc Electrophysiol. 2019. 30(11):2220-2228.
[9] Reed MJ, Grubb NR, Lang CC et al. Multi-centre Randomised Controlled Trial of a Smartphone-based Event Recorder Alongside Standard Care Versus Standard Care for Patients Presenting to the Emergency Department with Palpitations and Pre-syncope: The IPED (Investigation of Palpitations in the ED) study. EClinicalMedicine. 2019. 19(1):711.
[10] Koh KT, Law WC, Zaw WM et al. Smartphone electrocardiogram for detecting atrial fibrillation after a cerebral ischaemic event: a multicentre randomized controlled trial. Europace. 2021. 18;23(7):1016-1023.
[11] Caceres B, Hickey K, Bakken S, et al. Mobile Electrocardiogram Monitoring and Health-Related Quality of Life in Patients With Atrial Fibrillation. J Cardiovasc Nurs. 2020. 35(4):327-336.
[12] Guhl, E, Althouse A, Pusateri A, et al. The Atrial Fibrillation Health Literacy Information Technology Trial: Pilot Trial of a Mobile Health App for Atrial Fibrillation. JMIR Cardio. 2020. 4(1):17162.
[13] Narasimha N, Hanna N, Beck H et al. Validation of a smartphone-based event recorder for arrhythmia detection. Pacing Clin Electrophysiol. 2018. 41(5):487-494.
Photo – https://mma.prnewswire.com/media/1721631/AliveCor_KardiaMobile.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/nice-recommends-first-smartphone-based-ecg-for-the-detection-of-atrial-fibrillation-af-for-people-with-suspected-paroxysmal-af-in-an-ambulatory-monitoring-setting-301455792.html
SOURCE AliveCor
A few months into the coronavirus pandemic, it became clear that some people weren't recovering from the virus. They have come to be known as long haulers, and their condition, Long COVID. Researchers continue to study the strange manifestation of the virus. Research published in the medical journal Lancet had pinpointed nine of the top symptoms reported by long haulers, whose initial infections were severe. "Three quarters of patients hospitalized with COVID had at least one ongoing symptom 6 m
Get ready for a deluge of important approval decisions. This year, before April showers get a chance to bring any May flowers, the FDA is expected to make a slew of important approval decisions. Cancer patients in the U.S. could get some important new treatment options.
The holidays are behind us, the New Year is getting into full swing, and that means it’s time to figure out, if we can, just where we’re headed in 2022. Last year saw strong gains in the stock markets; the S&P 500 grew 29%, far above the 7% to 8% annual average. The big question for investors is, will the markets keep up this blistering pace? The general consensus is, it won’t – although that doesn’t mean we’re in for a bad year. John Stoltzfus, chief investment strategist with Oppenheimer, note
The U.S. continues to set records for new daily COVID-19 cases, as the super-contagious Omicron variant surges nationwide. "The margin of error with Omicron is much lower than with previous variants. Virtually every activity is riskier," warned Dr. Leana Wen in her Washington Post newsletter on Thursday. "In addition, in just about every setting, there is a much greater chance of encountering someone infected with the coronavirus." That's why it's important to be especially careful—in addition t
“This idea of natural immunity is not really panning out with this virus,” Dr. Hilary Fairbrother, an emergency medicine physician based in New York City, explained on Yahoo Finance Live.
COVID cases are rising rapidly across the U.S., having increased more than 85 percent in just the last week, as reported by the Centers for Disease Control and Prevention (CDC). In fact, the agency says numbers are skyrocketing so much, we've already more than doubled last year's peak in Jan. 2021, before vaccinations were available to the general public. It's all thanks to the new Omicron variant, which is already estimated to account for more than 95 percent of new infections in the U.S. And C
Health officials are advising adults and children to wear masks inside regardless of vaccination status to stop the spread of Omicron. These expert-approved masks can best protect you against contagious COVID-19 variants.
Fitness pros don’t believe the former secretary of state did it with turkey bacon and half-hour home workouts. | Editorial
Squeezing into a packed Tube train or sitting alongside fellow theatregoers might seem like obvious breeding grounds for Covid.
Florida reported 69,914 COVID-19 cases and three new deaths Friday, according to Saturday’s report to the Centers for Disease Control and Prevention, based on Miami Herald calculations of CDC data.
U.S. COVID hospitalizations approach record high, but new data could provide a silver lining
COVID-19 vaccination may cause a temporary change to a person's menstrual cycle, but it appears to be a "small change," according to a study published on Thursday.The study, published in the Obstetrics and Gynecology journal, examined close to 4,000 people – vaccinated and unvaccinated – and examined menstruation data that individuals entered through an app called Natural Cycles.Researchers then examined the difference between menstruation data…
The Supreme Court seems to be leaning toward striking down a federal vaccine mandate for large businesses.
Omicron, a new strain of COVID-19, was discovered less than two months ago, but is already causing chaos and disruption across the world. CNN reports COVID cases are up in India, 1 in 15 people in England tested positive in the week ending Dec. 31, 2021, Germany is seeing an uptick in cases and the highly contagious variant spread so quickly that the U.S. set a global record of 1 million new COVID cases reported in a single day. It's caused some schools to go virtual learning again and hospitali
Healthcare workers testing positive and asymptomatic for COVID-19 are allowed to return to work, according to new guidelines announced on Saturday by the California State Department of Public Health. No quarantine or testing is required. The latest rules go on to say that health care providers who have been "exposed and asymptomatic may return to work immediately without quarantine and without testing." However, an N-95 respirator must be worn. "It's a major disaster waiting to happen," said Zenei Triunfo-Cortez, President of the California Nurses Association. "I think it's callous and it's putting our patients and ourselves in grave danger."
Omicron is good at evading vaccines, so even if you've been vaccinated and boosted, you may still test positive.
Anita Louise Jackson, who faces federal charges, also helped lead the COVID-19 response of the Durham County Public Health Department.
Between the Omicron surge and the holiday season, long lines at COVID testing sites have become the norm. Increasingly, Americans are turning to another option: at-home rapid tests bought in stores or online. However, the Federal Trade Commission (FTC) is now warning of a dangerous new scam that could put your health in jeopardy: fake at-home COVID test kits."Using these fake products isn't just a waste of money, it increases your risk of unknowingly spreading COVID-19 or not getting the appropr
The Senate candidate didn’t disagree with the Fox News host’s disinformation about COVID-19 vaccine booster shots. | Editorial
Can we all collectively agree that simply being able to live shouldn't cost quite so much?View Entire Post ›

source


Leave a Reply

Your email address will not be published.